Novartis Investigative Site

Kurashiki, Okayama-ken 712-8064

0 studies enrolling now · 12 studies all time

What they study most

Asthma, Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive, Gastrointestinal Stromal Tumor (GIST), Lupus Nephritis, Metastatic Renal Cell Carcinoma, Non-small Cell Lung Cancer, Rheumatoid Arthritis, Sjogren Syndrome, Sjogren's Syndrome, Sjogrens Syndrome, Sjögren Syndrome

Studies at this site

A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome. — Running, not enrolling
Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome — Running, not enrolling
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP — Running, not enrolling
Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome — Completed
Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome — Completed
Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis — Stopped early
Dose Finding Study for QAW039 in Asthma — Completed
Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents — Completed
A Study of Nilotinib Versus Imatinib in GIST Patients — Completed
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer — Completed
Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX) — Completed
RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib — Completed